FIELD: medicine.
SUBSTANCE: free fatty acids concentration in arterial and venous blood is determined, the obtained free fatty acids concentration values are compared to the reference interval, while an the increased concentration of free fatty acids in arterial and venous blood compared to the reference interval and increased concentration of free fatty acids in arterial blood compared to venous blood, fat embolism syndrome is diagnosed.
EFFECT: expansion of the laboratory diagnostics capability in terms of fat embolism syndrome diagnosis for patients in various critical states.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR LABORATORY DIAGNOSIS OF FAT EMBOLISM SYNDROME IN PATIENTS WITH TRAUMA | 2016 |
|
RU2686078C2 |
| METHOD OF EARLY DIAGNOSTICS OF FAT EMBOLISM SYNDROME IN CASE OF FRACTURES OF LONG TUBULAR BONES AND PELVIS BONES | 2013 |
|
RU2545805C2 |
| METHOD FOR FAT EMBOLISM SYNDROME DIAGNOSIS IN CASE OF LOWER LIMB BONE FRACTURES | 2016 |
|
RU2611363C1 |
| METHOD FOR PREDICTION OF PROGRESSIVE CLINICAL COURSE OF EARLY FORMS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2768466C1 |
| METHOD OF DIAGNOSTICS OF METABOLIC SYNDROME BY ULTRASONIC LIPOMETRY | 2017 |
|
RU2677526C1 |
| METHOD FOR DIAGNOSING THE CASES OF INSULIN RESISTANCE SYNDROME | 1999 |
|
RU2153170C1 |
| PHYSIOLOGICALLY ACTIVE SUBSTANCE SRFM AS BLOOD BIOMARKER FOR DIAGNOSING HUMAN NEURODEGENERATIVE DISORDERS AND DISEASES | 2023 |
|
RU2822604C1 |
| METHOD FOR CORRECTION OF ABDOMINAL TYPE OBESITY AND METABOLIC SYNDROME | 2021 |
|
RU2761727C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF CRANIOCEREBRAL INJURY | 2011 |
|
RU2456620C1 |
| METHOD FOR FAT EMBOLISM SYNDROME PREVENTION FOR PATIENTS WITH MULTIPLE INJURIES IN CASE OF LONG BONES FRACTURES | 2016 |
|
RU2620858C1 |
